Inositec Company
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs. Its lead programs address vascular and renal calcification disorders, including orphan indications.
The company was founded in 2015 as a spin-off of ETH Zurich.
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Drug Discovery & Development
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41442710755
Investors:
VI Partners, Venture Kick, VentureOut, Z?rcher Kantonal Bank
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Mattias Ivarsson